Over the years, we’ve heard hundreds of time about how we have enough nuclear weapons to destroy the world. But is that ...

AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.

Oppenheimer analyst Ken Wong lowered the firm’s price target on Bill (BILL) to $90 from $110 and keeps an Outperform rating on the shares. The ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to treat vision-threatening eye diseases, including wet age‐related macular degeneration (wet AMD) and diabetic ...

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

Director Christopher Nolan is set to reunite with one of the stars from his multi-award-winning film Oppenheimer for his next ...

Oppenheimer (NYSE:OPY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday. Oppenheimer Trading ...

British consumers’ appetite for home entertainment reached new heights in 2024, with the sector surpassing £5.1 billion ($6.4 ...